Rheumatology Research

Dec 1, 2024 | link.springer.com | Rheumatology Research |a Johnson |Drexel College

AbstractPsoriatic arthritis (PsA) is a chronic, multidomain, inflammatory disease requiring long-term treatment. Guselkumab, a fully human interleukin [IL]-23p19-subunit inhibitor, and the IL-17A inhibitors (IL-17Ai) ixekizumab and secukinumab are approved by the US Food and Drug Administration (FDA) for adults with active PsA. Real-world data evaluating on-label treatment persistence is an important consideration for patients.

Feb 29, 2024 | acrjournals.onlinelibrary.wiley.com | Philip Mease |Rheumatology Research |Alexis Ogdie |John R.P. Tesser

INTRODUCTION Psoriatic arthritis (PsA) is a chronic, systemic, inflammatory disease that can negatively affect patients’ health-related quality of life (HRQoL) because of pain, fatigue, psychological distress, and impaired physical function.1-3 In studies in which patients used questionnaires to rate the impact of disease on their lives, pain was ranked as the PsA symptom that most profoundly affects patients’ HRQoL,3, 4 and pain often persists despite treatment with approved therapies.5...

Nov 21, 2023 | ard.bmj.com | Leonard Calabrese |Philip Mease |Rheumatology Research

Improving the nosology of Long COVID: it is not so simple Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.